A new Lyme disease vaccine made by Pfizer and Valneva could lower infection rates of the tick-borne illness, but federal ...

Vaccine maker's critics hope for new attorney general to reverse Pam Bondi's hostility to clinical trial whistleblower's ...

Pfizer and Valneva are moving forward with regulatory approval for their experimental Lyme disease vaccine after it ...

After GSK’s Lymerix, the only Lyme disease vaccine ever approved, was pulled from the market in 2002 amid a safety ...

ROANOKE, Va. (WDBJ) - Pfizer said it plans to seek regulatory approval of a new vaccine for Lyme disease. Vaccines for Lyme ...

A new vaccine to prevent Lyme disease in humans may soon be available. Pfizer said it's planning to seek regulatory approval.

When the topic of Lyme disease comes up, Robert F. Kennedy Jr. often tells a story about standing in a bathtub in Westchester ...

BURLINGTON, Vt. (WCAX) - Pfizer said it plans to seek regulatory approval of a new Lyme disease vaccine. It comes as Vermont ...

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, though ...

If approved, the Pfizer-Valneva vaccine could become highly sought-after as tick-borne illnesses surge in the Hudson Valley.

Catalyst Pharmaceuticals Inc. advanced stock charts by Barron's. View CPRX historical stock data and compare to other stocks, and exchanges.

Pfizer logo (Photo Illustration by Nikolas Kokovlis/NurPhoto via Getty Images) (NEW YORK) — Earlier this week, pharmaceutical company Pfizer and its partner Valneva announced that an experimental Lyme ...